Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
5.88
-0.22 (-3.61%)
At close: May 23, 2025, 4:00 PM
6.02
+0.14 (2.38%)
After-hours: May 23, 2025, 4:46 PM EDT
Treace Medical Concepts Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for Treace Medical Concepts stock ranges from a low of $8.00 to a high of $14.5. The average analyst price target of $9.18 forecasts a 56.12% increase in the stock price over the next year.
Price Target: $9.18 (+56.12%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Treace Medical Concepts stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 7 | 7 | 7 | 7 | 7 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $10 → $8.6 | Hold | Maintains | $10 → $8.6 | +46.26% | May 9, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $9.5 → $8 | Hold | Maintains | $9.5 → $8 | +36.05% | Apr 11, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $10 → $9.5 | Hold | Maintains | $10 → $9.5 | +61.56% | Mar 13, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $8.4 → $10 | Hold | Maintains | $8.4 → $10 | +70.07% | Mar 3, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +146.60% | Dec 31, 2024 |
Financial Forecast
Revenue This Year
231.56M
from 209.36M
Increased by 10.61%
Revenue Next Year
255.54M
from 231.56M
Increased by 10.36%
EPS This Year
-0.84
from -0.90
EPS Next Year
-0.68
from -0.84
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 238.7M | 269.9M | 294.8M |
| Avg | 231.6M | 255.5M | 277.0M |
| Low | 222.2M | 241.1M | 259.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 14.0% | 16.5% | 15.3% |
| Avg | 10.6% | 10.4% | 8.4% |
| Low | 6.1% | 4.1% | 1.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.80 | -0.46 | -0.16 |
| Avg | -0.84 | -0.68 | -0.51 |
| Low | -0.93 | -0.78 | -0.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.